Aim: The aim of this study was to compare the activity of the autonomic nervous system (ANS) using heart rate variability (HRV) in 'healthy' young smokers and non-smokers before, during and after exogenous hypoxic provocation. Methods: Twenty-one healthy non-smoking males aged 28.0 ± 7.4 years (mean ± SD) and 14 'healthy' smoking males aged 28.1 ± 4.3 years with 9.2 ± 5.6 pack-years were subjected to one-hour hypoxic exposure (F i O 2 = 12.3 ± 1.5%) via a hypoxicator. HRV data was derived via Kubios HRV, Finland software by analysing the pre-hypoxic, hypoxic and post-hypoxic periods. Results: Standard deviation of the intervals between normal beats (SDNN) was higher in the non-smokers in the prehypoxic period (62.0 ± 32.1 vs 40.3 ± 16.2 ms, p = 0.013) but not in the hypoxic period (75.7 ± 34.8 vs 57.9 ± 18.3 ms, p = 0.167). When comparing intra-group HRV changes, shifting from hypoxic to normoxic conditions, there was an increase in the mean square root of successive R-R interval differences (RMSSD) (65.9 ± 40.2 vs 75.1 ± 45.9 ms, p = 0.011), but these changes were observed in only the group of non-smokers. Conclusions: Smoking probably impairs autonomic regulation in healthy young males and may lead to decreased HRV, even before subjective clinical signs and symptoms appear.
1
It is well known that tobacco smoke impairs the respiratory and cardiovascular systems and is associated with high-burden diseases, such as coronary artery disease (CAD), stroke, sudden cardiac death and chronic obstructive pulmonary disease (COPD). Some of these pathological conditions are considered a result of the impaired autonomic regulation caused by smoking. 2 It has been proven that nicotine increases the activity of the sympathetic nervous system (SNS) and plasma catecholamine levels. Therefore it can cause tachycardia and vasoconstriction, which could contribute to cardiovascular morbidity. 3 Heart rate variability (HRV) is a commonly used method for assessment of autonomic dysfunction. [4] [5] [6] Manzano et al. established that tobacco smoking leads to acute changes in autonomic control associated with sympathetic over-activation and diminished vagal activity. These changes in the autonomic nervous system (ANS) continue for approximately 30 minutes after a single cigarette is smoked. 7 Regular smoking also leads to long-term effects such as permanent sympathetic predominance [decreased overall variability and increased low-frequency/high-frequency (LF/HF) index] in subjects without significant health problems and on average 15 pack-years of smoking. 8, 9 Smokers also have decreased reactivity to vagal stimulation tests such as the Valsalva manoeuvre. This could be associated with decreased baroreflex sensitivity, which normally leads to parasympathetic activation. 10, 11 There is frequent speculation in alpine practice that smokers are more resistant to hypoxia as a result of the daily hypoxic 'training' while smoking. This statement is disputable, since nicotine does not increase the hypoxic ventilatory response (HVR) and peripheral chemoreceptor sensitivity (PCS). 12 There is no widely accepted consensus about the effects of smoking on autonomic control during hypoxic exposure and more research is needed. Furthermore, there are no data about the activity of the ANS after removal of the hypoxic factor. The aim of our study was to compare the activity of the ANS via HRV in 'healthy' young smokers and non-smokers before, during and after a short-term exogenous hypoxic exposure.
Methods
Twenty-one healthy male non-smokers and 16 'healthy' male smokers with 9.2 ± 5.6 (mean ± SD) pack-years were included in the study. All the subjects had regular physical activity and no clinical symptoms or diagnosis. The age of the participants and other antropometric data are shown in Table 1 . Two of the tested subjects in the smoking group were excluded from the analysis due to more than 15% premature cardiac contractions. Therefore 14 smokers completed the study protocol.
Official permission for the study was obtained by the ethics committee of the Medical University of Plovdiv with a protocol reference number P-1548/13.03.2014. Guidelines for proper human care were fully implemented, following the Helskinki agreement and human rights. The subjects received all relevant information about the study, including its aim, protocol, tests and any potential side effects. A signed informed consent was obtained from all subjects prior to inclusion in the study and a questionnaire about their physical status was completed.
During the experimental session, the participants did not take any medication, coffee, alcohol or tobacco for at least two hours prior to the test. A physical examination was carried out, including an electrocardiogram (ECG), which was reviewed by a cardiologist to exclude cardiovascular abnormalities or any rhythm or conductive disorders. No side effects or symptoms were reported during the session.
The subjects were placed in a supine position on a comfortable bed, in a quiet, well-aerated room with constant light and ambient temperature, in the absence of any distracting factors. They were instructed to stay calm, without excessive voluntary movements or speaking and to breathe normally. During the first 10 minutes of the visit, the participants breathed ambient air at an altitude of 130 m (Plovdiv, Bulgaria). Subsequently, air with an oxygen concentration of 12.3 ± 1.5%, corresponding to an altitude of about 4 200 m, was administered for one hour via a full-face mask using a hypoxicator (AltiPro 8850 Summit+, Altitude Tech, Canada). The protocol did not include any changes in the barometric pressure (normobaric hypoxia).
At the end of the hypoxic session, the mask was removed and the subjects were exposed to ambient air. Four-channel ECG (H3+, Mortara Instruments, Milwaukee, USA) and pulse oximetry (CMS50F, Contec Medical Systems, Qinhuangdao, China) were recorded during the whole time. The ECG recordings were reviewed and R-R intervals were extracted automatically by H-Scribe 5 software (Mortara Instruments, Milwaukee, USA).
Five-minute samples were selected from the end of the pre-hypoxic and hypoxic periods, and immediately after hypoxic exposure for the subsequent analysis. After removing trends, data were analysed using Kubios HRV software and domain, and frequency domain and non-linear parameters were calculated. 13 Fast Fourier transform was used for calculation of the frequency domain parameters using Welch's periodogram with a window length of 256 seconds and 50% overlap.
The following parameters were derived from the R-R data: total power (TP) and standard deviation of the intervals between normal beats (SDNN) as measures of overall autonomic regulation; absolute power and normalised units (nu) of highfrequency (0.15-0.40 Hz) and low-frequency (0.04-0.15 Hz) spectral components, respectively, reflecting parasympathetic nervous system (PNS) activity and combined sympathetic (SNS) and PNS activities. The ratio LF/HF was also calculated as an index of sympatho-vagal balance. The mean square root of successive R-R interval differences (RMSSD) is a time domain parameter associated with parasympathetic activity.
In addition to the linear methods described, three commonly used non-linear parameters were applied. These included standard deviations SD1 and SD2 of the Poincaré plot -SD1 related to fast beat-to-beat variability in data and SD2 describing longer-term variability of R-R. 14, 15 Sample entropy (SampEn) was also collated as an index for the overall complexity and predictability of HRV time series. 16 Statistical analysis was performed with the independent samples t-test (SPSS v.17.0) when comparing the group of smokers and non-smokers, and paired samples t-test was used to compare intra-group changes between hypoxic and posthypoxic periods. Normality of distribution was assessed with the Shapiro-Wilk test. Skewness of distribution of some parameters (absolute spectral powers) was normalised by means of natural logarithmic transformation. 
Results
There was no difference in peripheral capillary oxygen saturation (SpO 2 ) between smokers and non-smokers under normoxic conditions. However, the smokers had significantly higher oxygen saturation during the hypoxic exposure, but lower oxygen saturation in the post-hypoxic period. They also had higher mean heart rate (HR) during the whole session compared to the non-smokers. HRV analysis showed that SDNN was higher in non-smokers in the pre-hypoxic period but not during hypoxia. RMSSD, SD1, SD2 and SD1/SD2 were higher in the non-smokers during all three periods of the test. Sample entropy was higher in the group of non-smokers under normoxic but not hypoxic conditions (Table 2) . Frequency domain HRV analysis showed higher TP in the non-smokers only during the pre-hypoxic period. HF was lower in the smokers under both normoxic and hypoxic conditions. LF was also lower but only during the pre-hypoxic normoxia. Non-smokers had a lower LF/HF index under normoxic (preand post-hypoxia) conditions but no significant difference was found during hypoxic exposure (Fig. 1) .
When comparing intra-group changes of HRV when shifting from hypoxic to post-hypoxic (normoxic) conditions, we found that there was a significant increase in SDNN, RMSSD and HF and a decrease in LF/HF, but these changes were observed in only the group of non-smokers (Table 3) . Peak frequency for HF at the three different stages of the study was as follows: before (0.21 ± 0.06 ms ) and did not show significant difference (p = 1.000).
Discussion
When comparing groups of smokers and non-smokers under normoxic conditions before hypoxic exposure, there was no difference in the oxygen saturation, but smokers had significantly higher heart rates and lower HRV. This means that tobacco smoking leads to a decrease in the overall variability (total power and SDNN), lower vagal activity (RMSSD, HF and SD1), sympathetic predomination (higher LF/HF and lower SD1/SD2) ( Fig. 1 ) and lower complexity of the time series (sample entropy).
Impaired autonomic regulation in smokers has been studied previously. Manzano et al. found that smoking a single cigarette is a stress for the body and leads to a sudden change in autonomic control, associated with sympathetic activation and vagal withdrawal. These changes could be observed up to 30 minutes after smoking. 7 In our study, we tried to avoid the effect of acute tobacco smoking, therefore our subjects did not smoke for at least two hours prior to the test. We were thus able to assess the long-term consequences caused by smoking.
The results of our study are in concordance with other investigations who found impaired autonomic control with lower HRV parameters in 'heavy' smokers with more than 15 packyears.
8,9 Although our subjects were much younger and with less pack-years, we found the same HRV pattern. Even without any clinical signs and symptoms, smokers had sympathetic predominance (higher LF/HF and lower SD1/SD2). HRV could therefore be used in clinical practice for the assessment of impaired autonomic control in young smokers. Moreover, some studies have shown that HRV parameters significantly increased and LF/HF decreased after smoking cessation, which clearly demonstrates the benefit of cessation. 17 When comparing the groups during exogenous hypoxic exposure, we found that smokers had higher SpO 2 and HR, but significantly lower HRV parameters (RMSSD, HF, SD1, SD2, SD1/SD2), which means higher sympathetic activation as a result of hypoxic provocation. Sympathetic over-activation or higher SpO 2 in smokers could not be a result of higher ventilation compared to non-smokers since nicotine does not increase the peripheral chemoreceptor sensitivity and there was no difference in the peak frequency of HF, which suggests no difference in the respiratory rate of the two groups. 12, 18 Moreover, it is well known that chronic hypoxia causes pulmonary vasoconstriction and pulmonary hypertension, which leads to ventilation/perfusion mismatch and remodelling of the pulmonary vessels. 19, 20 Brewer et al. demonstrated that smoking workers of Leadville, Colorado (3 048 m) had higher haemoglobin affinity with oxygen compared to non-smokers, most probably caused by the higher levels of carboxyhaemoglobin, which shift the oxygen dissociation curve to the left. 21, 22 This could be a possible explanation for the higher SpO 2 of smokers during hypoxia but not during normoxia, since the difference in the oxygen dissociation curve of the two groups was higher in lower pO 2 (high altitude). 23 However, carboxyhaemoglobin levels were not part of the study design and further tests are needed to confirm this hypothesis. Wu et al. showed no difference in SpO 2 between smokers and non-smokers at 4 525 m. However the authors concluded that smoking slightly decreased the risk of acute mountain sickness but impaired long-term altitude acclimatisation. 24 This could be explained by the higher sympathetic activation found in smokers in our study. However, contrary to previous studies focused on autonomic control and oxygen saturation in smokers at high altitude, we used normobaric hypoxia in an indoor environment, with a constant temperature, higher than can be expected at high altitude, which are all factors that could affect the results.
The shift from hypoxic to normoxic conditions in non-smokers was associated with a sudden increase of SpO 2 and overall variability (SDNN), caused by parasympathetic activation (RMSSD, lnHF) (Fig. 2) , which is normally observed in the recovery period in subjects with good autonomic control, such as athletes. 25 Conversely, there was no change in HRV parameters in smokers and the LF/HF index even increased, which was evident in demonstrating the absence of parasympathetic response when the hypoxic stimulus was removed. The absence of autonomic response was most probably a result of autonomic dysfunction in the smokers, which has previously been described in the literature. 9, 26 There is little data about the changes in activity of the ANS when shifting from hypoxic to normoxic environments. Since transition from hypoxic to normoxic conditions can induce PSNS activation, which was not observed in the smokers, our hypoxic provocation protocol could be applied in clinical practice as a test for early detection of autonomic dysfunction in smokers, even before the appearance of clinical signs.
Some study limitations of our research should be considered. We did not record the respiratory rate and tidal volume, therefore we do not have information on ventilation, which is known to affect HRV parameters. 15 However, the peak frequency of HF, which is suggested as an indirect index of respiratory rate, showed no changes during the different periods of the protocol. 18 We therefore assumed that ventilation of the examined subjects was stable.
The sample of the study was not large enough to produce more explicit results. Increasing the number of enrolled subjects would potentially decrease the impact of confounding factors affecting HRV. Additionally, even though we tried to control the environmental factors that can affect HRV results, there were more uncontrollable, non-quantifiable factors such as stress and quality of sleep that could have had an impact on the ANS and should be considered.
Conclusion
The results of our study show that smoking impaired the autonomic modulation in 'healthy' young smokers and led to a decreased HRV even before the appearance of any subjective clinical signs and symptoms. During acute exposure to exogenous hypoxia, smokers had higher SpO 2 but lower HRV parameters -RMSSD, lnLF, lnHF and Poincaré plot standard deviations SD1, SD2 and SD1/SD2 index. The data suggest that smokers have altered autonomic regulation under hypoxic conditions: diminished parasympathetic activity and sympathetic domination despite having higher SpO 2 . Transition from hypoxic to normoxic conditions leads to an increase in PSNS activity, which was observed in only the group of non-smokers. Therefore, a hypoxic exposure test could be used in clinical practice for early detection of autonomic dysfunction in smokers, because their parasympathetic reactivation is blunted when shifting from hypoxic to normoxic ambient conditions, as measured by HRV. 
